Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing

NCT00698607 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1466

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Everolimus-eluting stent (Xience or Promus)
DEVICE: Sirolimus-eluting stent (Cypher)
DRUG: 6-month clopidogrel therapy
DRUG: 12-month clopidogrel therapy

Sponsor

Seoul National University Hospital

Collaborators

[object Object]
[object Object]